EL300 AM Pill - white & yellow capsule/oblong, 16mm
Generic Name: elagolix/estradiol/norethindrone
Pill with imprint EL300 AM is White & Yellow, Capsule/Oblong and has been identified as Oriahnn elagolix 300 mg / estradiol 1 mg / norethindrone acetate 0.5 mg. It is supplied by AbbVie Inc.
Oriahnn is used in the treatment of Uterine Fibroids; Uterine Leiomyomata and belongs to the drug class sex hormone combinations. Oriahnn elagolix 300 mg / estradiol 1 mg / norethindrone acetate 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EL300 AM
Oriahnn
- Generic Name
- elagolix/estradiol/norethindrone
- Imprint
- EL300 AM
- Strength
- elagolix 300 mg / estradiol 1 mg / norethindrone acetate 0.5 mg
- Color
- White & Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Sex hormone combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-1017
See also:
Eligard
Eligard (leuprolide) reduces levels of testosterone and is used to treat prostate cancer. Includes ...
Lupron Depot
Lupron Depot is used to treat advanced prostate cancer, endometriosis, uterine fibroids, and ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Myfembree
Myfembree (relugolix, estradiol and norethindrone acetate) is used in premenopausal women for the ...
Estradiol/norethindrone/relugolix
Estradiol/norethindrone/relugolix is used for endometriosis, uterine fibroids
Leuprolide
Leuprolide is used to treat endometriosis, prostate cancer, and early-onset puberty. Includes ...
More about Oriahnn (elagolix / estradiol / norethindrone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: sex hormone combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.